Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
54.07
-2.99 (-5.24%)
At close: May 5, 2025, 4:00 PM
53.02
-1.05 (-1.94%)
Pre-market: May 6, 2025, 7:14 AM EDT
Tempus AI Employees
Tempus AI had 2,400 employees as of December 31, 2024. The number of employees increased by 100 or 4.35% compared to the previous year.
Employees
2,400
Change (1Y)
100
Growth (1Y)
4.35%
Revenue / Employee
$288,916
Profits / Employee
-$310,971
Market Cap
9.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
TEM News
- 22 hours ago - Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry - Business Wire
- 4 days ago - Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment - Business Wire
- 6 days ago - Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection - Business Wire
- 7 days ago - Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform - Business Wire
- 10 days ago - Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 - Business Wire
- 11 days ago - Tempus to Report First Quarter 2025 Financial Results on May 6 - Business Wire
- 12 days ago - Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology - Business Wire
- 14 days ago - Tempus AI: Cooldown Arrived (Rating Upgrade) - Seeking Alpha